Latest Breaking News On - Jasper therapeutics inc - Page 7 : comparemela.com

Jasper Therapeutics (NASDAQ:JSPR) Receives Outperform Rating from Oppenheimer

Jasper Therapeutics (NASDAQ:JSPR) Receives Outperform Rating from Oppenheimer
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William blairJasper therapeutics incFranklin resources incCitadel advisorsSphera funds managementOpaleye management incVanguard group incJasper therapeutics company profileSecurities exchange commissionJasper therapeuticsFree reportVelan capital investment managExchange commissionFunds managementGet free reportJasper therapeutics daily

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLauren walkerEdwin tuckerAlex grayJoyce allaireJasper therapeutics incAmerican academy of allergyAnnual meetingKit mouseWendy pangSenior vice presidentChief medicalAbstract titlePrevents passive systemic anaphylaxisMice expressing chimeric humanMast cell depletion poster number

Jasper Therapeutics (JSPR) Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology

Jasper Therapeutics (JSPR) Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEdwin tuckerJasper therapeutics incAmerican academy of allergyJasper therapeuticsAnnual meetingKit mouseWendy pangSenior vice presidentChief medicalAbstract titlePrevents passive systemic anaphylaxisMice expressing chimeric humanMast cell depletion poster numberTherapeutic trialsAllergic skin disorders

Jasper Therapeutics Presents Data From Preclinical Briquilimab Studies At The American Academy Of Allergy, Asthma, And Immunology (AAAAI) Annual Meeti

Jasper Therapeutics Presents Data From Preclinical Briquilimab Studies At The American Academy Of Allergy, Asthma, And Immunology (AAAAI) Annual Meeti
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireLauren walkerEdwin tuckerAlex grayAmerican academy of allergyJasper therapeutics incAnnual meetingWendy pangSenior vice presidentTranslational medicineChief medical officerPrevents passive systemic anaphylaxisMice expressing chimeric humanMast cell depletionTherapeutic trials

Jasper Therapeutics, Inc (NASDAQ:JSPR) Short Interest Update

Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 276,200 shares, a growth of 43.5% from the January 15th total of 192,500 shares. Based on an average daily volume of 109,400 shares, […]

United statesWilliam blairSecurities exchange commissionJasper therapeutics incGeode capital managementAmerica corpBlackrock incJasper therapeutics company profileFranklin resources incSphera funds managementJasper therapeuticsGet free reportVelan capital investment managExchange commissionFunds managementCapital management